A searchable database of
medically documented cases

About the Project

Lymphoma

Lymphoma

Epidemiology

Lymphoma ranks among the most significant hematological malignancies worldwide, with an estimated global incidence of approximately 605,000 cases reported annually in 2020.¹ In the United States, the annual incidence of lymphoma is estimated to be about 89,010 new cases, with approximately 21,080 deaths each year, highlighting the substantial public health impact of this disease.² Despite advances in therapies, lymphoma remains a significant contributor to cancer-related mortality across regions.³ The occurrence of spontaneous remission (SR) in lymphoma is remarkably rare, with documented rates often below 2%, and the true incidence may be further obscured due to underreporting and lack of recognition of remissions that are less pronounced.⁴

Clinical Characteristics:

A total of 205 well-documented cases of spontaneous remission (SR) in lymphoma have been reported between 1956 and 2025. The ages of affected individuals ranged from 2 to 94 years (mean ≈ 52.2 years), with a near-equal male-to-female ratio of approximately 1.1:1 and a peak incidence observed in the 60–80-year age group. Overall, SR was documented across a wide age spectrum but occurred more frequently in older adults, with remission most often noted in generalized or disseminated disease rather than localized lesions, involving both nodal and extranodal sites. See table 1 below for further information.

Histological Characteristics:

Patients who experienced spontaneous remission of lymphoma typically presented with lymphadenopathy or extranodal masses confirmed histologically as malignant lymphoid proliferations. Most cases involved advanced or systemic disease, with the lymph nodes, spleen, and bone marrow as the predominant primary sites, and occasional involvement of the skin, gastrointestinal tract, central nervous system, or thyroid. Remission was verified by follow-up biopsies or imaging demonstrating regression or disappearance of lymphoma cells. Nearly all SR cases showed durable clinical stability or long-term remission, far exceeding the expected prognosis for untreated lymphoma.

Proposed Contributing Mechanisms:

Several mechanisms have been proposed to explain spontaneous remission in lymphoma. The most common involve immune activation following bacterial or viral infections, febrile illnesses, or other inflammatory events. Additional contributing factors include biopsy-related immune stimulation, recovery after withdrawal of immunosuppressive or cytotoxic therapy such as methotrexate or cyclosporine, and immune restoration following discontinuation of antiretroviral or other immunomodulatory treatments. A minority of reports suggest cellular processes such as apoptosis, cytokine-mediated tumor inhibition, or radiation-related immune enhancement as potential contributors.

Site and Extent of Remission:

In most reported cases of spontaneous remission in lymphoma, regression occurred within nodal sites, including cervical, axillary, mediastinal, and abdominal lymph nodes. Extranodal remissions were also documented, involving the skin, gastrointestinal tract, central nervous system, thyroid, breast, and other organs. In many patients, remission extended across multiple regions, reflecting systemic disease resolution rather than localized tumor regression. The duration of remission ranged from a few weeks to more than 20 years, with a considerable number of patients maintaining prolonged clinical and radiologic remission in the absence of active treatment.

Table 1: Leukemia SR Cases and Clinical Characteristics

Author–year

Age/sex

Primary site

Remission site

Proposed mechanisms

Follow-up

Anday et al., 19561

68/M

Lymph nodes and liver

Lymph nodes and liver

Humoral factors

4 years

Diwani et al., 19602

2.5/M

Neck

Neck lymph nodes

Not reported

Not reported

Tigerightt et al., 19623

43/M

Mediastinal and axillary nodes

Paratracheal nodes and skin

Infection-related immune response

Not reported

Tigerightt et al., 19623

56/F

Submandibular and cervical nodes

Axillary node

Infection-related immune response

Not reported

Kwittken et al., 19664

83/F

Scalp

Scalp

Not reported

15 months

Burkitt & Kyalwazi, 19675

9/M

Jaw

Jaw

Not reported

Not reported

Burkitt & Kyalwazi, 19675

6/M

Mandible and maxilla

Mandible and maxilla

Not reported

14 months

Burkitt & Kyalwazi, 19675

36/F

Breast and shoulder

Breast and shoulder

Not reported

Not reported

Burkitt & Kyalwazi, 19675

4/F

Maxilla and orbit

Maxilla and orbit

Infection-related immune response

2 years

Burkitt, 19676

Not reported

Blood

Blood, bone marrow

Immunological response

Not reported

David & Burkitt, 19687

9/M

Maxilla, orbit, intracranial

Maxilla and orbit

Immunological response

2 months

David & Burkitt, 19687

11/M

Maxilla

Maxilla

Immunological response

7 years

David & Burkitt, 19687

6/F

Maxilla and abdomen

Not reported

Not reported

3 months

David & Burkitt, 19687

7/F

Maxilla and abdomen

Not reported

Not reported

3 months

David & Burkitt, 19687

15/M

Maxilla and orbit

Maxilla and orbit

Immunological response

3 years

David & Burkitt, 19687

9/M

Maxilla, orbit, intracranial

Maxilla and orbit

Immunological response

10 months

David & Burkitt, 19687

9/M

Maxilla

Maxilla

Immunological response

Not reported

David & Burkitt, 19687

6/M

Maxilla and abdomen

Maxilla and abdomen

Immunological response

2 years

Kiely & Harrison, 19708

16/M

Inguinal node

Inguinal and mediastinal nodes

Immunologic factors

5 years

Jamra et al., 19709

12/F

Face, iliac fossa, ovary

Face and ovaries

Not reported

3 months

Bluming & Ziegler, 197110

8/M

Orbit

Orbit

Infection-related immune response

4 months

Ziegler, 197611

Not reported

Blood

Blood

Antitumor immunity

Not reported

Gattiker et al., 198012

Not reported

Not reported

Not reported

Not reported

several years

Krikorian et al., 198013

42/M

Lymph nodes

Lymph nodes

Not reported

5 years

Krikorian et al., 198013

43/F

Nodes

Peripheral and thoracic nodes

Not reported

32 months

Krikorian et al., 198013

68/F

Nodes

Peripheral and abdominal nodes

Not reported

2 years

Krikorian et al., 198013

42/M

Nodes

Peripheral and abdominal nodes

Not reported

5 years

Weingarten et al., 198314

61/M

Intracerebral

Intracerebral

Steroid effect

5 months

Weingarten et al., 198314

60/F

Intracerebral

Left temporal lobe

Steroid effect

4 years

Weingarten et al., 198314

69/F

Intracerebral

Intracerebral

Not reported

3 months

Weingarten et al., 198314

69/F

Frontal lobe

Frontal lobe

Not reported

4 months

Horning et al., 198415

Not reported

Not reported

Lymph nodes

Viral infection, interferon effect

5–10 years

McClain et al., 198516

12/F

Gastrointestinal tract, reproductive organs, CNS

Bone marrow

Infection-related immune response

11 months

Weaver et al., 198517

69/F

Mediastinum

Mediastinum

Hormonal factors

27 days

Grem et al., 198618

54/F

Tongue base

Cervical node

Infection-related immune response

4 years

Rubin et al., 198719

56/F

CNS

CNS

Steroid-induced cytotoxicity

Not reported

Strauchen et al., 198720

84/M

GI (stomach, antrum)

Stomach

Immunomodulatory effect

10 months

Strauchen et al., 198720

73/M

GI (stomach, antrum)

Gastric antrum

Immunomodulatory effect

16 months

Poppema et al., 198821

12/M

Tonsil and cervical node

Tonsil and cervical node

Host cytotoxic response

3 years

Sugita et al., 198822

63/F

CNS

Frontal and parietal lobes

Immune response

Not reported

Shigematsu et al., 198923

40/F

Stomach (pyloric antrum)

Stomach

Not reported

69 months

Shigematsu et al., 198923

73/M

Stomach (posterior antrum)

Stomach

Not reported

44 months

Wolf, 198924

56/F

Axilla and groin nodes

Epitrochlear and inguinal nodes

Infection-related immune response

>20 years

Drobyski et al., 198925

Not reported

Not reported

Not reported

Immune response, infection

Not reported

Fric et al., 199026

21/M

Brain

Brain

Immunosuppression withdrawal

Not reported

Aelbrecht & Geerights, 199027

75/F

Skin

Cutaneous lesions

Not reported

10 months

Mayou et al., 199128

43/F

Skin

Cutaneous nodules

Not reported

6 months

Daniels et al., 199229

43/M

Pharynx

Cervical nodes

Infection-related immune response

Infection-related immune response

Karnad et al., 199230

30/M

Skin and chest wall

Forehead and chest wall tumors

Immune response, interferon activity

Not reported

Terriff et al., 199231

34/M

Central nervous system

Thalamus and midbrain lesion

Tumor necrosis

Not reported

Grigg et al., 199232

67/M

Lymph nodes

Bone marrow and lymph nodes

Viral infection, immune response

16 months

Motley et al., 199233

27/F

Skin

Skin

Infection-related immune response

Not reported

Kiyohara et al., 200034

62/F

Intravascular (skin and bone marrow)

Skin and bone marrow

Not reported

Not reported

Ranheim et al., 200035

35/M

Oral cavity, lung, bowel, spleen

Oral cavity, lung, bowel, spleen

Not reported

9 years

Takezako et al., 200036

79/F

Lymph nodes

Lymph nodes (inguinal, para-aortic)

Infection-induced immune response

18 months

Takenaka et al., 200037

76/M

Rectum

Rectum

Not reported

19 months

Phanish et al., 200238

52/F

Spleen

Spleen

Not reported

14 months

Baird et al., 200239

69/F

Cervical lymph nodes

Cervical lymph nodes

Methotrexate withdrawal

14 months

Ohgi et al., 200240

61/F

Lumbar spine

Lumbar spine

Not reported

8 months

Mangel et al., 200341

47/M

Mediastinum (lymph nodes)

Mediastinum, and axillary lymph nodes

Not reported

15 months

Koga et al., 200342

78/F

Gingiva (left maxillary)

Gingiva (left maxillary)

Immune response

36 months

Kon et al., 200343

61/M

CNS (corpus callosum, tectum)

Corpus callosum

Not reported

3.5 years

Ogata et al., 200444

70/M

Stomach

Stomach

Withdrawal of cyclosporine treatment

10 months

Heibel et al., 200445

70/M

Oral cavity (mandible)

Oral cavity (mandible)

Biopsy-induced apoptosis

20 months

Iihara et al., 200446

46/F

Breast (right)

Breast (right)

Biopsy-induced immune response

7 years

Chang et al., 200447

40/F

Conjunctiva

Conjunctiva and orbit

Biopsy-induced immune activation

5 weeks

Kumar et al., 200448

45/M

Left axillary lymph nodes

Left axillary, mediastinal, and para-aortic lymph nodes

Not reported

6 months

Kumar et al., 200448

59/F

Left parotid lymph node

Inguinal lymph nodes

Not reported

5 years

Kumar et al., 200448

75/M

Posterior cervical lymph nodes (left neck)

Cervical lymph nodes

Not reported

14 months

Ugurlu & Bartley, 200449

76/M

Orbital apex

Orbital apex, frontal lobe

Not reported

2 years

Thonhofer et al., 200550

64/F

Sinuses

Sinuses

Methotrexate withdrawal

6 months

Futagami et al., 200551

36/M

Subcutaneous tissue (left thigh)

Subcutaneous tissue (left thigh)

Biopsy-induced immune response

6 months

Parekh et al., 200552

47/M

Cecum

Cecum

Antiretroviral therapy for HIV

5.5 years

Kamiya et al., 200653

72/M

Skin (left forearm)

Skin (left forearm)

Not reported

1 year

Kamiya et al., 200653

32/F

Skin (right cheek)

Skin (right cheek)

Not reported

2 years

Sakuma et al., 200654

70/F

Intraoral mucosa

Hard palate

Post-biopsy immune activation

38 months

Svensson et al., 200655

48/F

Bone marrow

Abdominal lymph nodes, bone marrow

Methotrexate withdrawal

12 months

Partap & Spence, 200656

45/M

CNS

CNS

Immune response

18 months

Matsuo et al., 200757

72/M

Bilateral conjunctiva

Bilateral conjunctiva

Not reported

24 months

Patel et al., 200758

35/F

Left axilla

Left axilla

Not reported

2 years

Shimada et al., 200759

54/F

Lungs

Lungs, liver, spleen

Methotrexate withdrawal

3 months

Armstrong et al., 200760

35/M

Oral cavity

Oral cavity

HAART-induced immune restoration

1 month

Abe et al., 200761

89/M

Inguinal lymph node

Inguinal and cervical lymph nodes

Immune modulation

31 months

Rujirojindakul et al., 200762

26/M

Submandibular gland

Lymph nodes

Immune response

6 months

Mohsin et al., 200763

48/M

Skin (anterior chest wall and back)

Skin (anterior chest wall and back)

Not reported

24 months

Daly et al., 200864

56/M

Oral cavity

Oral cavity

Biopsy-induced immune activation

4 years

McCabe et al., 200865

2/M

Right mastoid

Right mastoid

Not reported

24 months

Isobe et al., 200966

65/F

Skin (eyelid)

Submandibular lymph node

EBV-related immune activation

5 years

Chiu et al., 200967

64/M

Skin (right leg)

Skin (right leg)

Reduction of immunosuppression

9 months

Engel & Lee, 200968

Elderly/M

Cervical lymph nodes

Cervical, axillary, and tonsillar regions

Trauma-related immune activation

4 weeks

Makino et al., 201069

38/M

Ileum mucosa

Ileum mucosa

Not reported

24 months

Rampisela & Donner, 201070

14/M

Lymph nodes

Lymph nodes

Not reported

4 years

Iwatani et al., 201171

69/F

Breast

Breast

Biopsy-induced immune response

Not reported

Norimura et al., 201172

59/F

Duodenum

Duodenum

Not reported

3-4 months

Norimura et al., 201172

76/F

Duodenum

Duodenum

Not reported

Not reported

Norimura et al., 201172

76/M

Duodenum

Duodenum

Not reported

Not reported

Norimura et al., 201172

72/M

Duodenum

Duodenum

Not reported

7 months

Norimura et al., 201172

67/F

Duodenum

Duodenum

Not reported

7 months

Norimura et al., 201172

72/F

Duodenum

Duodenum

Not reported

Not reported

Gencoglan et al., 201173

48/F

Skin (left forearm)

Skin (left forearm)

Biopsy-induced apoptosis

10 months

Cassaday et al., 201174

54/F

Intra-abdominal lymph nodes

Liver, spleen, and intra-abdominal lymph nodes

Withdrawal of adalimumab

3 months

Kameda et al., 201275

12/F

Cervical lymph nodes

Cervical lymph nodes, skin

Not reported

4 weeks

Kase et al., 201276

80/M

Eye

Intraocular tissues

Immune response, CD8 T cells

8 months

Buckner et al., 201277

67/F

Maxillary sinus

Maxillary sinus

Infection-induced immunity

1 year

Mohsen et al., 201278

86/F

Lymph nodes

Lymph nodes

Immune response

8 months

Biswas & Tan, 201279

8/F

Skin

Left areola

Apoptosis

6 years

Zhang et al., 201380

24/F

Central nervous system and lungs

Brain and lung lesions

Improved immunity

1 year

Udupa et al., 201381

10/F

Lymph nodes

Lymph nodes, bone marrow, liver

Immune response

14 months

Mizuno et al., 201382

94/F

Lymph nodes

Lymph nodes

Immune recovery

10 months

Humeniuk et al., 201483

63/M

Lymph nodes

Lymph nodes

Not reported

12 months

Sekiguchi et al., 201484

68/F

Left breast

Left breast

Not reported

14 months

Rojas-Hernandez et al., 201485

57/M

Stomach

Gastric

Not reported

2 years

Kang et al., 201586

57/F

Lung

Lung

Apoptosis of lymphocytes

3 months

Kaibuchi et al., 201587

87/M

Gingiva

Gingiva

Biopsy-induced immune stimulation

2.5 years

Birendra et al., 201588

55/M

Kidney

Kidney

Immune reconstitution

10 months

Bekoz et al., 201589

38/M

Lymph nodes

Axillary lymph nodes

Biopsy-induced trauma

Not reported

Igawa et al., 201590

80/M

Oral cavity

Gingiva

Immune response

5 months

Takahashi et al., 201591

61/F

Blood

Bone marrow

Apoptosis

6 years

Kato et al., 201592

60/F

Lymph nodes

Supraorbital region

Immune response

36 months

Ureshino & Miyahara, 201693

58/F

Blood

Blood and skin

Immune response

58 months

Ayala et al., 201694

62/M

Skin

Right cheek

Not reported

12 months

Ogihara et al., 201695

66/M

Urinary bladder

Urinary bladder

Recovery from immunosuppression

Not reported

Sasaki et al., 201696

83/F

Thyroid

Thyroid

Radiation exposure

9 years

Sasaki et al., 201696

51/F

Thyroid

Thyroid

Radiation exposure

8 years

Sasaki et al., 201696

60/M

Ileocecal region

Ileocecal region

Radiation exposure

Not reported

Sasaki et al., 201696

69/F

Thyroid

Thyroid

Radiation exposure

21 years

Fukushima et al., 201697

72/F

Lung

Lung

Biopsy-induced immune activation

40 months

Potts et al., 201798

59/M

Lymph nodes

Para-aortic lymph nodes

Biopsy-induced immune response

12 months

Hees et al., 201799

20/M

Skin

Left alar base

Not reported

4 months

Cornish et al., 2017100

66/M

Lymph nodes

Lymph nodes and spleen

Not reported

52 months

Chan et al., 2017101

74/M

CNS

CNS

Immune response

2 years

Jimura et al., 2017102

72/F

Skin

Left arm

Immune response

21 months

Miyagawa et al., 2017102

46/M

Skin

Lip

Biopsy-induced immune activation

14 months

Fleming et al., 2018103

51/F

Breast

Breast

Not reported

Not reported

Fleming et al., 2018103

24/F

Breast

Breast

Not reported

Not reported

Ye et al., 2018104

48/M

Right inguinal lymph node

Lymph nodes

Immune response

5 years

Ye et al., 2018104

63/M

Right axillary lymph node

Lymph nodes

Immune response

3 years

Ye et al., 2018104

68/M

Inguinal and cervical lymph nodes

Lymph nodes

Immune response

5 years

Ye et al., 2018104

44/F

Inguinal and pelvic lymph nodes

Lymph nodes, Bone marrow

Immune response

1.5 years

Froehlich et al., 2018105

44/F

Skin

Skin

Drug withdrawal immune restoration

4 weeks

Graham et al., 2018106

79/M

Skin

Left leg

Immune response

12 months

Ramos et al., 2018107

50/F

Brain

Brain

Viral infection–induced NK cell activation

Not reported

Toberer et al., 2018108

66/M

Skin

Left lower leg

Immune response

Not reported

Aiko et al., 2018109

79/M

Lung

Lung

MTX withdrawal immune recovery

1 month

Swoboda et al., 2018110

66/M

Skin

Skin

Not reported

Few months

Pasvolsky et al., 2019111

32/F

Lymph nodes

Lymph nodes

Not reported

2 years

Snijder et al., 2019112

88/F

Lymph nodes

Lymph nodes

Biopsy-induced immune response

3 months

Tanaka et al., 2019113

35/M

Small intestine

Small intestine, Lymph nodes

PD-L1/PD-1–mediated apoptosis

3 months

Yordanova et al., 2019114

69/M

Bone marrow

Bone marrow, Spleen

Not reported

6 weeks

Hosoda et al., 2019115

70/M

Bronchi

Bronchi

Not reported

Not reported

Morigi et al., 2019116

47/M

Lymph nodes

Lymph nodes, Bone marrow, Spleen, Stomach

Immune response

3 months

Nakamoto et al., 2020117

74/M

Liver

Liver, Spleen, Bone

Immune-mediated response

1.5 months

Tang et al., 2020118

78/M

Skin

Skin

Not reported

8 months

Fleming et al., 2020119

24/F

Breast

Breast

Not reported

Not reported

Fleming et al., 2020119

51/F

Breast

Breast

Not reported

2 months

Stanoszek et al., 2021120

35/M

Retroperitoneum

Retroperitoneum

Biopsy-induced immune response

6 months

Furukawa et al., 2021121

76/F

Vagina

Vagina, Lung

Not reported

1 year

Gambichler et al., 2021122

57/M

Lymph nodes

Lymph nodes

Vaccine-induced immune activation

1 month

Desana et al., 2021123

54/F

Cervix

Cervix

Biopsy-induced immune response

Not reported

Peeters et al., 2021124

59/M

Cheek

Cheek

T-cell–mediated immunity

5.5 months

Gong et al., 2021125

65/F

Vitreous

Vitreous

Not reported

1 week

Sherkat et al., 2022126

11/F

Lymph nodes

Lymph nodes, Spleen

Infection-related immune activation

Several months

Aoki et al., 2022127

84/M

Gingiva

Gingiva

Drug withdrawal effect

Not reported

Lee et al., 2022128

61/M

Sinus

Sinus

Biopsy-induced immune response

Not reported

Ogawa et al., 2022129

63/F

Breast

Breast, lung, retroperitoneum

Methotrexate withdrawal

6 months

Kongwattananon et al., 2022130

80/M

Eye

Eye

Not reported

1 year

Gan et al., 2023131

71/F

Eye

Eye

Biopsy-induced immune response

6 months

Hayashino et al., 2023132

55/F

Pleura, Pericardium

Pleura, Pericardium

Not reported

Not reported

Li et al., 2023133

62/M

Skin

Skin

Biopsy-induced immune response

3 months

Aizawa et al., 2023134

15/M

Maxillary bone

Maxillary bone

Not reported

8 months

Abla et al., 2023135

3/M

Lymph nodes

Lymph nodes

Not reported

3 weeks

Khaw et al., 2024136

32/M

Colon

Brain, Colon

Immune reconstitution

1 year

Winkler et al., 2024137

53/F

Skin

Skin

Reactive T-cell infiltration

9 years

Tomai et al., 2024138

27/F

Mediastinum

Mediastinum, Lymph nodes

Feto-maternal microchimerism

6 months

Goto et al., 2024139

75/F

Mandible

Mandible, Lungs

MTX withdrawal immune recovery

6 months

Teoh et al., 2025140

35/M

Skin

Skin

Immune reconstitution

3 months

Li et al., 2025141

72/M

Lung

Lung

Biopsy-induced immune response

5 months

Moreno et al., 1991142

79/M

Forehead and anterior scalp

2 months

Moreno et al., 1991142

83/M

Face, neck, trunk

6 months

Weintraub, 1969143

68/M

Axillary and inguinal regions

Spleen and liver

Interferon production

4 weeks

Buchi et al., 1983144

76/F

Lymph nodes

Lymph nodes

Immune reaction

Lymphadenopathies disappeared by April 1980

Buchi et al., 1983144

76/F

Lymph nodes

T lymphocyte subset imbalance

Kwittkin & Goldberg et al., 1966145

83/F

Scalp

Scalp

Local trauma considered

8 months

Kirikorian et al., 1980146

42/M

Lymph nodes

Lymph nodes

Host immunity and environmental factors

Asymptomatic at 5 years

Kirikorian et al., 1980146

68/F

Lymph nodes

Lymph nodes

Host immunity

Asymptomatic at 2 years

Kirikorian et al., 1980146

43/F

Lymph nodes

Lymph nodes

Host immunity

32 months

Stevanovic & Majcan et al., 1961147

26/F

Face, genital area

Forehead tumor, genital tumor

Progressive fibrosis, inflammatory process

Discharged 2 months after admission

Stevanovic & Majcan et al., 1961147

36/M

Back

Connective tissue alteration

Gurcay, 1969148

16/M

Mediastinal mass and cervical lymph nodes

Cervical lymph nodes and mediastinal mass

Surgical exploration and procaine role

Monthstanaro & Patton et al., 1976149

61/F

Spleen

Removal of the spleen

11 years

Williams, 1980150

46/M

Skin

Skin nodules

2.5 years

Green et al., 1984151

48/F

Lymph nodes

Complete remission until Feb 1981

Green et al., 1984151

42/M

Lymph nodes

Complete remission

Hernandez et al., 2013152

65/M

Cerebral, right frontal CC

Cerebral lesions

Immune theory

4 months, asymptomatic

Alcantara-Gozalez et al., 2014153

82/F

Skin on right leg

Skin lesions

Infiltrate contributed to regression

4 weeks

Gonzalez et al., 2015154

44/M

Left nasal ala

Left nasal ala

Asymptomatic after 1 year

Marrero-Aleman et al., 2017155

83/F

Back of right leg

Back of right leg

Immune response against tumor cells

Asymptomatic after 1 year

Monthszen et al., 2013156

85/M

Prostate

Pelvic lymph nodes

Immunological response post-biopsy

31 months

Adiquzel et al., 2009157

89/M

Body cavities

Pleural effusion

None reported

40 months

Blokx et al., 2012158

65/F

Skin ulcer

Skin ulcer

Antiviral treatment and reduced immunosuppression

18 months

Korner et al., 2011159

53/M

Brain (CNS)

Deep white matter of right hemisphere

Infarction and necrosis

Symptom free, remarkable tumor reduction

Lelievre, 2005160

52/M

Lymph nodes and spleen

Lymph nodes

Discontinuation of cyclosporine

30 months, psoriasis controlled

Parekh & Koduri et al., 2003161

46/M

Lymph nodes, spleen, liver

Left axilla

4 weeks post-surgery

Tamas et al., 2011162

66/F

Tongue

7 years, untreated

Nishimura, 2021163

23/F

Bilateral areolae

Bilateral areolae

Self-limited disease or biopsy-triggered regression

6 months

Takatsu, 2021164

69/M

Brain

Right deep white matter

Regression and progression of inflammation

7 days

Han & Sokal et al., 1971165

69/F

Lymph nodes and liver

Normal lymphocyte count reached in September 1966

Getzen, 1967166

41/F

Spontaneous remission, normal coagulation studies

Houbouyan et al., 1984167

2/F

Spontaneous and quick recovery

Ziliotto & Miotto et al., 1980168

80/F

Lymph nodes

Fiorillo et al., 1981169

Spontaneous remission

Matthews et al., 1988170

Lymphoid stem cell clone development

18 years


References

  1. Anday GJ, Schmitz HL, Limarzi LR. Follicular lymphoma with full remission of leukemic phase. AMA Arch Intern Med. 1956;97(5):631–638. doi:10.1001/archinte.1956.00250230125014
  2. Diwani M, Gabr M, Essawy M, Elwi A. Malignant Lymphoma in Childhood. Arch Pediatr. 1960;77(10):406–420.
  3. Tigerightt WD, Crosby WH, Berge TO, Howie DL, Kress S, Dangerfield HG, Bass JW, Frank W. The virus of Venezuelan equine encephalomyelitis as an antineoplastic agent in man. Cancer. 1962;15:628–632. doi:10.1002/1097-0142(196205/06)15:3<;628::AID-CNCR2820150326>3.0.CO;2-A
  4. Kwittken J, Goldberg AF. Follicular Lymphoma of the Skin. Arch Dermatol. 1966;93:177–183.
  5. Burkitt DP, Kyalwazi SK. Spontaneous remission of African lymphoma. Br J Cancer. 1967;21(1):14–16. doi:10.1038/bjc.1967.2
  6. Burkitt DP. Clinical Evidence Suggesting the Development of an Immunological Response Against African Lymphoma. In: Burchenal JH, Burkitt D, eds. Treatment of Burkitt’s Tumour. UICC Monograph Series, Vol 8. New York: Springer-Verlag; 1967:197–208.
  7. David J, Burkitt D. Burkitt’s lymphoma: remissions following seemingly non-specific therapy. Br Med J. 1968;4(5626):288–289. doi:10.1136/bmj.4.5626.288
  8. Kiely JM, Harrison EG Jr. Long-term remission in Hodgkin’s disease after nitrogen mustard therapy. Cancer. 1970;26(4):800–802. doi:10.1002/1097-0142(197010)26:4<;800::AID-CNCR2820260409>3.0.CO;2-T
  9. Jamra M, Carvalho RP, Dalldorf G. Evolution of an atypical case of Burkitt lymphoma. Lancet. 1970;2(7674):672. doi:10.1016/S0140-6736(70)91449-2
  10. Bluming AZ, Ziegler JL. Regression of Burkitt’s lymphoma in association with measles infection. Lancet. 1971;2(7715):105–106. doi:10.1016/S0140-6736(71)92086-1
  11. Ziegler JL. Spontaneous Remission in Burkitt’s Lymphoma. Natl Cancer Inst Monogr. 1976;44:61–65.
  12. Gattiker HH, Wiltshaw E, Galton DAG. Spontaneous Regression in Non-Hodgkin’s Lymphoma. Cancer. 1980;45(10):2627–2632.
  13. Krikorian JG, Porightlock CS, Cooney P, Rosenberg SA. Spontaneous regression of non-Hodgkin’s lymphoma: a report of nine cases. Cancer. 1980;46(9):2093–2099. doi:10.1002/1097-0142(19801101)46:9<;2093::AID-CNCR2820460931>3.0.CO;2-4
  14. Weingarten KL, Zimmerman RD, Leeds NE. Spontaneous regression of intracerebral lymphoma. Radiology. 1983;149(3):721–724. doi:10.1148/radiology.149.3.6359262
  15. Horning SJ, Rosenberg SA. The Natural History of Initially Untreated Low-Grade Non-Hodgkin’s Lymphomas. N Engl J Med. 1984;311(23):1471–1475.
  16. McClain K, Warkentin P, Kay N. Spontaneous remission of Burkitt's lymphoma associated with herpes zoster infection. Am J Pediatr Hematol Oncol. 1985;7(1):9–14.
  17. Weaver GR, Cohn JH, Mintzer RA. Transient spontaneous regression of an anterior mediastinal mass. Chest. 1985;87(4):547–548. doi:10.1378/chest.87.4.547
  18. Grem JL, Hafez GR, Brandenburg JH, Carbone PP. Spontaneous remission in diffuse large cell lymphoma. Cancer. 1986;57(10):2042–2044. doi:10.1002/1097-0142(19860515)57:10<;2042::AID-CNCR2820571027>3.0.CO;2-#
  19. Rubin M, Libman I, Brisson ML, Goldenberg M, Brem S. Spontaneous temporary remission in primary CNS lymphoma. Can J Neurol Sci. 1987;14(2):175–177. doi:10.1017/S0317167100026354
  20. Strauchen JA, Moran C, Goldsmith M, Greenberg M. Spontaneous regression of gastric lymphoma. Cancer. 1987;60(8):1872–1875. doi:10.1002/1097-0142(19871015)60:8<;1872::AID-CNCR2820600833>3.0.CO;2-6
  21. Poppema S, Postma L, Brinker M, de Jong B. Spontaneous regression of a small non-cleaved cell malignant lymphoma (non-Burkitt’s lymphoblastic lymphoma). Morphologic, immunohistological, and immunoglobulin gene analysis. Cancer. 1988;62(4):791–794. doi:10.1002/1097-0142(19880815)62:4<;791::AID-CNCR2820620425>3.0.CO;2-M
  22. Sugita Y, Shigemori M, Yuge T, Iryo O, Kuramoto S, Nakamura Y, Morimatsu M. Spontaneous regression of primary malignant intracranial lymphoma. Surg Neurol. 1988;30(2):148–152. doi:10.1016/0090-3019(88)90102-4
  23. Shigematsu A, Iida M, Lien GS, Imamura T, Okada M, Fuchigami T, Fujishima M, Itoh H, Iwashita A. Spontaneous regression of primary malignant lymphoma of the stomach in two nontreated Japanese. J Clin Gastroenterol. 1989;11(5):511–517. doi:10.1097/00004836-198910000-00006
  24. Wolf JW. Prolonged spontaneous remission of case of malignant lymphoma. Mo Med. 1989;86(5):275–277.
  25. Drobyski WR, Qazi R. Spontaneous Regression in Non-Hodgkin’s Lymphoma: Clinical and Pathogenetic Considerations. Am J Hematol. 1989;1:138–141.
  26. Fric M, Hartmann A, Klehr HU, Pfeifer U, Herberhold C. Regression of cerebral post-transplantation lymphoma under cyclosporin A reduction. Klin Wochenschr. 1990;68(23):1189-1194. doi:10.1007/BF01815278
  27. Aelbrecht M, Geerights ML. Lymphoplasmocytoid immunocytoma. Dermatologica. 1990;180(3):191–192.
  28. Mayou SC, Anstey A, Norighton AJ, et al. Angiocentric T-cell lymphoma in skin. J R Soc Med. 1991;84(11):683–684.
  29. Daniels D, Lowdell CP, Glaser MG. The spontaneous regression of lymphoma in AIDS. Clin Oncol (R Coll Radiol). 1992;4(3):196–197. doi:10.1016/S0936-6555(05)81090-8
  30. Karnad AB, Jaffar A, Lands RH. Spontaneous regression of acquired immune deficiency syndrome-related, high-grade, extranodal non-Hodgkin’s lymphoma. Cancer. 1992;69(7):1856–1857. doi:10.1002/1097-0142(19920401)69:7<;1856::AID-CNCR2820690730>3.0.CO;2-Q
  31. Terriff BA, Harrison P, Holden JK. Apparent spontaneous regression of AIDS-related primary CNS lymphoma mimicking resolving toxoplasmosis. J Acquir Immune Defic Syndr. 1992;5(9):953–954.
  32. Grigg AP, Gray GR, Shepherd JD. Spontaneous remission of multilobated non-Hodgkin lymphoma. Am J Hematol. 1992;40(3):222–225. doi:10.1002/ajh.2830400312
  33. Motley RJ, Jasani B, Ford AM, Poynton CH, Calonje-Daly JE, Holt PJ. Regressing atypical histiocytosis, a regressing cutaneous phase of Ki-1-positive anaplastic large cell lymphoma. Cancer. 1992;70(2):476–483. doi:10.1002/1097-0142(19920715)70:2<;476::AID-CNCR2820700216>3.0.CO;2-5
  34. Kiyohara T, Kumakiri M, Kobayashi H, Shimizu T, Ohkawara A, Ohnuki M. A case of intravascular large B-cell lymphoma mimicking erythema nodosum: the importance of multiple skin biopsies. J Cutan Pathol. 2000;27(8):413–418. doi:10.1034/j.1600-0560.2000.027008413.x
  35. Ranheim EA, Jones C, Zehnder JL, Warnke R, Yuen A. Spontaneously relapsing clonal, mucosal cytotoxic T-cell lymphoproliferative disorder: case report and review of the literature. Am J Surg Pathol. 2000;24(2):296-301. doi:10.1097/00000478-200002000-00017
  36. Takezako Y, Kanda Y, Arai C, Takezako N, Shirai Y, Hirano N, Togawa A. Spontaneous remission in acute type adult T-cell leukemia/lymphoma. Leuk Lymphoma. 2000;39(1-2):217-222. doi:10.3109/10428190009053558
  37. Takenaka R, Tomoda J, Sakata T, Ichiba T, Motoi M, Mizuno M, Tsuji T. Mucosa-associated lymphoid tissue lymphoma of the rectum that regressed spontaneously. J Gastroenterol Hepatol. 2000;15(3):331-335. doi:10.1046/j.1440-1746.2000.02086.x
  38. Phanish MK, Owen A, Parry DH. Spontaneous regression of acquired C1 esterase inhibitor deficiency associated with splenic marginal zone lymphoma presenting with recurrent angio-oedema. J Clin Pathol. 2002;55(10):789–790. doi:10.1136/jcp.55.10.789
  39. Baird RD, van Zyl-Smit RN, Dilke T, Scott SE, Rassam SM. Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature. Br J Haematol. 2002;118(2):567–568. doi:10.1046/j.1365-2141.2002.03619.x
  40. Ohgi S, Ehara S, Satoh T, Kato S, Shimosegawa K, Ishida Y. Spontaneous regression of malignant lymphoma of the lumbar spine. Skeletal Radiol. 2002;31(2):99–102. doi:10.1007/s00256-001-0446-z
  41. Mangel J, Barth D, Berinstein NL, Imrie KR. Spontaneous regression of Hodgkin’s disease: two case reports and a review of the literature. Hematology. 2003;8(3):191–196. doi:10.1080/1024533031000107514
  42. Koga M, Kusukawa J, Hayabuchi N. Spontaneous regression of extranodal malignant lymphoma occurred in the gingiva. Oral Oncol. 2003;39(3):323–324. doi:10.1016/s1368-8375(02)00122-7
  43. Kon T, Kakita A, Koide A, et al. A primary CNS lymphoma in spontaneous remission for 3.5 years after initial detection of the lesions by MRI. Brain Tumor Pathol. 2003;20:27–31. doi:10.1007/BF02478944
  44. Ogata M, Kikuchi H, Ono K, Ohtsuka E, Gamachi A, Kashima K, Nasu M. Spontaneous remission of Epstein-Barr virus-negative non-Hodgkin's lymphoma after withdrawal of cyclosporine in a patient with refractory anemia. Int J Hematol. 2004;79(2):161–164. doi:10.1532/ijh97.03095
  45. Heibel H, Knödgen R, Bredenfeld H, Wickenhauser C, Scheer M, Zöller JE. Complete spontaneous remission of an aggressive non-Hodgkin’s lymphoma with primary manifestation in the oral cavity. Leuk Lymphoma. 2004;45(1):171–174. doi:10.1080/1042819031000139747
  46. Iihara K, Yamaguchi K, Nishimura Y, Iwasaki T, Suzuki K, Hirabayashi Y. Spontaneous regression of malignant lymphoma of the breast. Pathol Int. 2004;54(7):537–542. doi:10.1111/j.1440-1827.2004.01652.x
  47. Chang YC, Chang CH, Liu YT, Tsai KB, Liu TC, Lin YN. Spontaneous regression of a large-cell lymphoma in the conjunctiva and orbit. Ophthal Plast Reconstr Surg. 2004;20(6):461–463. doi:10.1097/01.iop.0000144791.05993.64
  48. Kumar R, Bhargava P, Zhuang H, Yu JQ, Schuster SJ, Alavi A. Spontaneous regression of follicular, mantle cell, and diffuse large B-cell non-Hodgkin's lymphomas detected by FDG-PET imaging. Clin Nucl Med. 2004;29(11):685–688. doi:10.1097/00003072-200411000-00002
  49. Ugurlu S, Bartley GB. Evolution of an orbital apex tumor over a decade. Ophthal Plast Reconstr Surg. 2004;20(1):75-77. doi:10.1097/01.IOP.0000105740.40210.66
  50. Thonhofer R, Gaugg M, Kriessmayr M, Neumann HJ, Erlacher L. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment. Ann Rheum Dis. 2005;64(7):1098-1099. doi:10.1136/ard.2004.026252
  51. Futagami A, Aoki M, Kawana S. A case of peripheral T-cell lymphoma unspecified involving subcutaneous tissue. Leuk Lymphoma. 2005;46(5):785–788. doi:10.1080/10428190500051406
  52. Parekh S, Heberit T, Ratech H, Sparano J. Variable problems in lymphomas: Case 3. Spontaneous regression of HIV-associated Burkitt’s lymphoma of the cecum. J Clin Oncol. 2005;23(31):8116–8117. doi:10.1200/JCO.2005.08.079
  53. Kamiya T, Saga K, Yanagisawa K, Kaneko R, Yamashita T, Ishida O, Jimbow K. Small cell variant of CD30+ primary cutaneous T‐cell lymphoma with epidermotropism that completely regressed after incisional skin biopsy. Br J Dermatol. 2006;155(2):484–487. doi:10.1111/j.1365-2133.2006.07337.x
  54. Sakuma H, Okabe M, Yokoi M, Eimoto T, Inagaki H. Spontaneous regression of intraoral mucosa-associated lymphoid tissue lymphoma: molecular study of a case. Pathol Int. 2006;56(6):331-335. doi:10.1111/j.1440-1827.2006.01967.x
  55. Svensson AM, Jacobson ER, Ospina D, Tindle BH. Reversible Epstein-Barr virus-negative lymphadenopathy and bone marrow involved by Hodgkin’s lymphoma in a rheumatoid arthritis patient undergoing long-term treatment with low-dose methotrexate: a case report and review of the literature. Int J Hematol. 2006;83(1):47-50. doi:10.1532/IJH97.NA0503
  56. Partap S, Spence AM. Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man. J Neurooncol. 2006;80(3):305–307. doi:10.1007/s11060-006-9192-3
  57. Matsuo T, Ichimura K, Yoshino T. Spontaneous regression of bilateral conjunctival extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. J Clin Exp Hematop. 2007;47(2):79–81. doi:10.3960/jslrt.47.79
  58. Patel P, Godwin J, Velankar M, Alkan S. Nodal ALK positive anaplastic large cell lymphoma of the axilla with spontaneous regression. Leuk Lymphoma. 2007;48(6):1250–1252. doi:10.1080/10428190701342026
  59. Shimada K, Matsui T, Kawakami M, Nakayama H, Ozawa Y, Mitomi H, Tohma S. Methotrexate‐related lymphomatoid granulomatosis: a case report of spontaneous regression of large tumours in multiple organs after cessation of methotrexate therapy in rheumatoid arthritis. Scand J Rheumatol. 2007;36(1):64-67. doi:10.1080/03009740600902403
  60. Armstrong R, Bradrick J, Liu YC. Spontaneous regression of an HIV-associated plasmablastic lymphoma in the oral cavity: a case report. J Oral Maxillofac Surg. 2007;65(7):1361–1364. doi:10.1016/j.joms.2005.12.039
  61. Abe R, Ogawa K, Maruyama Y, Nakamura N, Abe M. Spontaneous regression of diffuse large B-cell lymphoma harbouring Epstein-Barr virus: a case report and review of the literature. J Clin Exp Hematop. 2007;47(1):23–26. doi:10.3960/jslright.47.23
  62. Rujirojindakul P, Kayasut K, Rohitoprakarn M, Lekhakula A. A unique case of transient spontaneous regression complicated with tumor lysis syndrome of T-cell lymphoblastic lymphoma in HIV-infected patient without antiretroviral therapy. J Med Assoc Thai. 2007;90(9):1930-1933.
  63. Mohsin N, Budruddin M, Kamble P, Khalil M, Pakkyarra A, Jha A, Mohammed E, Ahmed H, Ahmed J, Thomas S, Campistol JM, Daar A. Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus. Transplant Proc. 2007;39(4):1267–1271. doi:10.1016/j.transproceed.2007.03.092
  64. Daly RM, Healy CM, Toner ME, Flint SR. Spontaneous regression of non-Hodgkin's lymphoma in the oral cavity after incisional biopsy. Br J Oral Maxillofac Surg. 2008;46(3):223–225. doi:10.1016/j.bjoms.2007.03.010
  65. McCabe MG, Hook CE, Burke GA. Spontaneous regression of an EBV-associated monoclonal large B-cell proliferation in the mastoid of a young child following surgical biopsy. Pediatr Blood Cancer. 2008;51(4):557–559. doi:10.1002/pbc.21637
  66. Isobe Y, Aritaka N, Sasaki M, Oshimi K, Sugimoto K. Spontaneous regression of natural killer cell lymphoma. J Clin Pathol. 2009;62(7):647–650. doi:10.1136/jcp.2008.062976
  67. Chiu LS, Choi PCL, Luk NM, Chang M, Tang WY. Spontaneous regression of primary cutaneous Epstein–Barr virus-positive, CD30-positive anaplastic large T-cell lymphoma in a heart-transplant recipient. Clin Exp Dermatol. 2009;34:e21–e24. doi:10.1111/j.1365-2230.2008.03145.x
  68. Engel PA, Lee C. Sudden appearance and spontaneous regression of diffuse large B cell lymphoma in a man with a broken arm. BMJ Case Rep. 2009;2009:bcr10.2008.1036. doi:10.1136/bcr.10.2008.1036
  69. Makino Y, Suzuki H, Nishizawa T, Kameyama K, Hisamatsu T, Imaeda H, Mukai M, Hibi T. Ileal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma with a Large-Cell Component That Regressed Spontaneously. Gut Liver. 2010;4(1):117–121. doi:10.5009/gnl.2010.4.1.117
  70. Rampisela D, Donner LR. An unusual self-limited clonal Mott cell proliferation with lymphoplasmacytic lymphoma-like features in a child with the Wiskott-Aldrich syndrome and von Recklinghausen’s neurofibromatosis. Pathol Res Pract. 2010;206(7):467-471. doi:10.1016/j.prp.2009.07.003
  71. Iwatani T, Kawabata H, Miura D, Ota Y, Ohashi K. Complete spontaneous regression of primary diffuse large B-cell lymphoma of the breast. J Clin Oncol. 2011;29(5):e113-e115. doi:10.1200/JCO.2010.31.2801
  72. Norimura D, Isomoto H, Imaizumi Y, Akazawa Y, Matsushima K, Inoue N, Yamaguchi N, Ohnita K, Shikuwa S, Arima T, Hayashi T, Takeshima F, Miyazaki Y, Nakao K. Case series of duodenal follicular lymphoma, observed by magnified endoscopy with narrow-band imaging. Gastrointest Endosc. 2011;74(2):428–434. doi:10.1016/j.gie.2011.03.1237
  73. Gencoglan G, Ozturk F, Inanir I, Miskioglu M, Temiz P, Gunduz K. Primary cutaneous anaplastic CD30+ large-cell lymphoma that completely regressed after incisional skin biopsy. Cutan Ocul Toxicol. 2011;30(2):163–166. doi:10.3109/15569527.2010.534749
  74. Cassaday RD, Malik JT, Chang JE. Regression of Hodgkin lymphoma after discontinuation of a tumor necrosis factor inhibitor for Crohn's disease: a case report and review of the literature. Clin Lymphoma Myeloma Leuk. 2011;11(3):289–292. doi:10.1016/j.clml.2011.03.018
  75. Kameda G, Kempf W, Oschlies I, Michael K, Seifert G, Längler A. Nodal anaplastic large-cell lymphoma ALK-1− with CD30+ cutaneous lymphoproliferation treated with mistletoe: spontaneous remission or treatment response? Klin Padiatr. 2011;223(6):364–367. doi:10.1055/s-0031-1285914
  76. Kase S, Namba K, Jin XH, Kubota KC, Ishida S. Spontaneous regression of intraocular lymphoma. Ophthalmology. 2012;119(5):1083–1084. doi:10.1016/j.ophtha.2011.12.011
  77. Buckner TW, Dunphy C, Fedoriw YD, van Deventer HW, Foster MC, Richards KL, Park SI. Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infections. Clin Lymphoma Myeloma Leuk. 2012;12(6):455–458. doi:10.1016/j.clml.2012.06.007
  78. Mohsen A, Ghanem H, El-Bayoumi J, Tabbara I. Spontaneous regression of classical Hodgkin lymphoma: a case report and review of the literature. Clin Adv Hematol Oncol. 2012;10(11):762–764.
  79. Biswas A, Tan BB. Spontaneous regression of a childhood tumour with anaplastic histological features. Clin Exp Dermatol. 2013;38(3):318–320. doi:10.1111/j.1365-2230.2012.04427.x
  80. Zhang YX, Ding MP, Zhang T, Tang YL, Guo Y, Fan J, Chen LR, Chen Q. Lymphomatoid granulomatosis with CNS involvement can lead to spontaneous remission: case study. CNS Neurosci Ther. 2013;19(7):536–538. doi:10.1111/cns.12109
  81. Udupa K, Philip A, Rajendranath R, Sagar T, Majhi U. Spontaneous regression of primary progressive Hodgkin's lymphoma in a pediatric patient: a case report and review of literature. Hematol Oncol Stem Cell Ther. 2013;6(3-4):112–116. doi:10.1016/j.hemonc.2013.06.004
  82. Mizuno T, Ishigaki M, Nakajima K, Matsue T, Fukushima M, Minato H, et al. Spontaneous remission of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly. Case Rep Oncol. 2013;6(2):269–274. doi:10.1159/000345572
  83. Humeniuk MS, Liang JJ, Howard M, Inwards DJ. Spontaneous complete remission of angioimmunoblastic T-cell lymphoma. Proc (Bayl Univ Med Cent). 2014;27(3):242–245. doi:10.1080/08998280.2014.11929126
  84. Sekiguchi Y, Shimada A, Imai H, Wakabayashi M, Sugimoto K, Nakamura N, Sawada T, Komatsu N, Noguchi M. Spontaneous regression of a clinically-advanced histologically low-grade follicular lymphoma involving the breast: case report and review of the literature. Indian J Hematol Blood Transfus. 2014;30(Suppl 1):320–324. doi:10.1007/s12288-014-0382-4
  85. Rojas-Hernandez CM, Coleman JF, Czuchlewski DR, Fekrazad MH. Spontaneous regression of high grade primary gastric lymphoma in an untreated viral hepatitis infection. Leuk Lymphoma. 2014;55(11):2643–2645. doi:10.3109/10428194.2014.887710
  86. Kang HS, Lee HY, Kim SJ, Kim SC, Kim YK, Park GS, Lee KY, Jung JI, Kang JY. An unusual presentation of pulmonary mucosa-associated lymphoid tissue lymphoma as diffuse pulmonary infiltrates with spontaneous regression. Cancer Res Treat. 2015;47(4):943–948. doi:10.4143/crt.2014.016
  87. Kaibuchi N, Okamoto T, Kataoka T, Kumasaka A, Ando T. A case of spontaneous regression of lymphoma in the mandibular gingiva after biopsy. Oral Maxillofac Surg Cases. 2015;1(3):33–37. doi:10.1016/j.omsc.2015.06.002
  88. Birendra KC, Afzal MZ, Wentland KA, Hashmi H, Singh S, Ivan E, Lakhani N. Spontaneous regression of refractory diffuse large B-cell lymphoma with improvement in immune status with ART in a patient with HIV: a case report and literature review. Am J Case Rep. 2015;16:347–352. doi:10.12659/AJCR.892883
  89. Bekoz HS, Kantarcioglu B, Tecimer T, Sargin D. Spontaneous regression of a systemic ALK (+) anaplastic large cell lymphoma carrying ALK gene rearrangement that developed after PPD tuberculin skin test. Leuk Lymphoma. 2016;57(2):480–482. doi:10.3109/10428194.2015.1058935
  90. Igawa T, Sato Y, Kawai H, Kondo E, Takeuchi M, Miyata-Takata T, Takata K, Yoshino T. Spontaneous regression of plasmablastic lymphoma in an elderly human immunodeficiency virus (HIV)-negative patient. Diagn Pathol. 2015;10:183. doi:10.1186/s13000-015-0421-y
  91. Takahashi T, Ikejiri F, Takami S, Okada T, Kumanomidou S, Adachi K, et al. Spontaneous regression of intravascular large B-cell lymphoma and apoptosis of lymphoma cells: a case report. J Clin Exp Hematop. 2015;55(3):151–156. doi:10.3960/jslrt.55.151
  92. Kato M, Uemura Y, Sato K, Tsuruoka Y, Yokoi S, Nishio Y, et al. Spontaneous remission in a patient with follicular lymphoma carrying T cell-rich neoplastic follicles and a new complex variant translocation of t(14;18): t(5;14;18)(p15;q32;q21.3). Leuk Lymphoma. 2015;56(7):2187–2189. doi:10.3109/10428194.2014.987767
  93. Ureshino H, Miyahara M. Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia. Ann Hematol. 2016;95(5):841–843. doi:10.1007/s00277-016-2624-z
  94. Ayala D, Ramón MD, Cabezas M, Jordá E. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma with expression of follicular T-helper cell markers and spontaneous remission. Actas Dermosifiliogr. 2016;107(4):357–359. doi:10.1016/j.ad.2015.10.012
  95. Ogihara K, Kosaka T, Kikuchi E, Hongo H, Mikami S, Oya M. Spontaneous regression of Epstein-Barr virus-positive primary diffuse large B-cell lymphoma of the urinary bladder after the cessation of enzalutamide. Clin Genitourin Cancer. 2016;14(2):e215–e218. doi:10.1016/j.clgc.2015.12.028
  96. Sasaki J, Kurihara H, Nakano Y, Kotani K, Tame E, Sasaki A. Apparent spontaneous regression of malignant neoplasms after radiography: report of four cases. Int J Surg Case Rep. 2016;25:40–43. doi:10.1016/j.ijscr.2016.05.049
  97. Fukushima K, Hirosako S, Tenjin Y, Mukasa Y, Kojima K, Saeki S, Okamoto S, Ichiyasu H, Fujii K, Kikukawa Y, Kawanaka K, Kohrogi H. Pulmonary mucosa-associated lymphoid tissue lymphoma with spontaneous regression after computed tomography-guided needle biopsy: a case report and summary of 8 reported cases. Intern Med. 2016;55(24):3655–3660. doi:10.2169/internalmedicine.55.6874
  98. Potts DA, Fromm JR, Gopal AK, Cassaday RD. Spontaneous remission of an untreated, MYC and BCL2 coexpressing, high-grade B-cell lymphoma: a case report and literature review. Case Rep Hematol. 2017;2017:2676254. doi:10.1155/2017/2676254
  99. Hees H, Geißler EM, Wolter M, Lamos C, Löser CR, Dippel E. Pyogenic variant of primary cutaneous CD30+ anaplastic large-cell lymphoma: spontaneous remission in a young adult. J Dtsch Dermatol Ges. 2017;15(9):952–955. doi:10.1111/ddg.13315
  100. Cornish N, Maybury B, Otton S. A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma. Br J Haematol. 2018;180(1):176. doi:10.1111/bjh.14959
  101. Chan AM, Huttner A, Baehring J. Disappearing leukoencephalopathy. Clin Neuroradiol. 2017;1–5. doi:10.1007/s00062-017-0650-4
  102. Jimura N, Fujii K, Baba A, Higashi Y, Kanekura T. Spontaneous regression of a primary cutaneous diffuse large B-cell lymphoma, leg type. J Dermatol. 2017;44(6):608–609. doi:10.1111/1346-8138.13496
  103. Fleming D, Stone J, Tansley P. Spontaneous regression and resolution of breast implant-associated anaplastic large cell lymphoma: implications for research, diagnosis and clinical management. Aesthetic Plast Surg. 2018;42(3):672–678. doi:10.1007/s00266-017-1064-z
  104. Ye H, Desai A, Gong T, Zeng D, Nomie K, Chen W, Wang W, Romaguera J, Wang ML. Spontaneous regression of mantle cell lymphoma: a report of four cases. Cancer Commun (Lond). 2018;38(1):30. doi:10.1186/s40880-018-0306-z
  105. Froehlich A, Schmidt S, Landsberg J, Bieber T, Wenzel J. Spontaneous Regression of Tumor-Stage Cutaneous T-Cell Lymphoma in a Multiple Sclerosis Patient After Discontinuing Fingolimod. Mult Scler. 2018;24(13):1785–1787. doi:10.1177/1352458518774444
  106. Graham PM, Richardson AS, Schapiro BL, Saunders MD, Stewart DM. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response. JAAD Case Rep. 2018;4(4):305–309. doi:10.1016/j.jdcr.2017.10.012
  107. Ramos R, Fernandes JS, Almeida M, Almeida R. A Rare Case of Spontaneous Remission and Relapse of a Primary Central Nervous System Lymphoma. Acta Med Port. 2018;31(12):777–783. doi:10.20344/amp.10198
  108. Toberer F, Mechtersheimer G, Jaschinski H, Enk A, Hakim-Meibodi L, Haenssle HA. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type. Acta Derm Venereol. 2018;98(6):608–609. doi:10.2340/00015555-2921
  109. Aiko N, Sekine A, Umeda S, et al. The Spontaneous Regression of Grade 3 Methotrexate-Related Lymphomatoid Granulomatosis: A Case Report and Literature Review. Intern Med. 2018;57(21):3163–3167. doi:10.2169/internalmedicine.0542-17
  110. Swoboda S, Technau-Hafsi K, May AM, Wolter M, Kern JS, Meiss F. Recurrent Ulceronecrotic Plaques and Nodules With Spontaneous Remission. J Dtsch Dermatol Ges. 2018;16(9):1155–1158. doi:10.1111/ddg.13626
  111. Pasvolsky O, Berger T, Bernstine H, Hayman L, Raanani P, Vidal L. Spontaneous Regression of Hodgkin Lymphoma: Case Report and Review of the Literature. Acta Haematol. 2019;141(1):14–18. doi:10.1159/000494422
  112. Snijder J, Mihyawi N, Frolov A, Ewton A, Rivero G. Spontaneous Remission in Diffuse Large Cell Lymphoma: A Case Report. J Med Case Rep. 2019;13(1):28. doi:10.1186/s13256-018-1937-z
  113. Tanaka Y, Ishihara M, Miyoshi H, Hashimoto A, Shinzato I, Ohshima K. Spontaneous Regression of Diffuse Large B-Cell Lymphoma in the Small Intestine With Multiple Lymphadenopathy. J Clin Exp Hematop. 2019;59(1):17–21. doi:10.3960/jslrt.18020
  114. Yordanova K, Stilgenbauer S, Bohle RM, et al. Spontaneous Regression of a Plasmablastic Lymphoma With MYC Rearrangement. Br J Haematol. 2019;186(6):e203–e207. doi:10.1111/bjh.16082
  115. Hosoda C, Ishiguro T, Takahashi N, Kamiishi N, Shimizu Y, Takayanagi N. Spontaneous Regression of Primary Endobronchial Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue. Respir Med Case Rep. 2019;27:100826. doi:10.1016/j.rmcr.2019.100826
  116. Morigi A, Casadei B, Argnani L, Cavo M, Zinzani PL. Spontaneous Remission of Follicular Lymphoma. Hematol Oncol. 2019;37(5):626–627. doi:10.1002/hon.2653
  117. Nakamoto R, Okuyama C, Oka S. Complete Spontaneous Regression of Hepatosplenic T-Cell Lymphoma After Surgical Biopsy. Clin Nucl Med. 2020;45(2):e88–e91. doi:10.1097/RLU.0000000000002782
  118. Tang X, Tang J, Liu W, Wang L. Primary Cutaneous Marginal Zone B-Cell Lymphoma With Unusual Manifestation and Spontaneous Regression. Indian J Dermatol Venereol Leprol. 2020;86(4):428–431. doi:10.4103/ijdvl.IJDVL_516_19
  119. Fleming D, Stone J, Tansley P. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management. Aesthet Plast Surg. 2020;44(4):1109–1115. doi:10.1007/s00266-020-01810-2
  120. Stanoszek LM, Smith LB, Grajewski K, Reneau JC, Wilcox R, Perry AM. Spontaneous Regression of High-Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements: Case Report and Literature Review. Clin Lymphoma Myeloma Leuk. 2021;21(2):e120–e125. doi:10.1016/j.clml.2020.09.006
  121. Furukawa Y, Ando J, Ando M, et al. Long-Term Spontaneous Regression of Stage IV Diffuse Large B-Cell Lymphoma. J Clin Exp Hematop. 2021;61(3):168–172. doi:10.3960/jslrt.21002
  122. Gambichler T, Boms S, Hessam S, et al. Primary Cutaneous Anaplastic Large-Cell Lymphoma With Marked Spontaneous Regression of Organ Manifestation After SARS-CoV-2 Vaccination. Br J Dermatol. 2021;185(6):1259–1262. doi:10.1111/bjd.20630
  123. Desana B, Balbo Mussetto A, Macera A, Mariani L, De Rosa G, Cirillo S. Rare case of uterine cervix lymphoma with spontaneous regression: case report. J Obstet Gynaecol Res. 2021;47(2):807-811. doi:10.1111/jog.14562
  124. Peeters M, Geusens J, Van der Cruyssen F, et al. Spontaneous Remission of an Infraorbital Follicular B-Cell Lymphoma: Case Report and Review of the Literature. Pathol Oncol Res. 2021;27:642433. doi:10.3389/pore.2021.642433
  125. Gong D, Aronow ME, Eliott D. Rapid, Spontaneous Resolution of Prominent Subretinal Infiltrate in Vitreoretinal Lymphoma. J Vitreoretin Dis. 2021;6(1):80–85. doi:10.1177/24741264211009804
  126. Sherkat R, Afshar Moghaddam N, Reisi N, Rezaei M. Spontaneous Regression of Diffuse Large B-Cell Lymphoma in a Patient With Ataxia-Telangiectasia. Adv Biomed Res. 2022;11:31. doi:10.4103/abr.abr_169_21
  127. Aoki Y, Hasegawa S, Miyabe S, Nagao T. Spontaneous Regression of Malignant Lymphoma of the Maxillary Gingiva Following Biopsy. Int J Oral Maxillofac Surg. 2022;51(9):1145–1148. doi:10.1016/j.ijom.2021.09.006
  128. Lee KT, Misron NA, Abdul Aziz N, Wong CH, Liew HK. Spontaneous Regression of Plasmablastic Lymphoma in an Immunocompetent Patient: Case Report and Review of the Literature. Case Rep Hematol. 2022;2022:1142049. doi:10.1155/2022/1142049
  129. Ogawa A, Nakagawa T, Kumaki Y, Hosoya T, Oda G, Mori M, Fujioka T, Kubota K, Onishi I, Uetake H. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature. J Med Case Rep. 2022;16(1):49. doi:10.1186/s13256-022-03274-1
  130. Kongwattananon W, Kumar A, Simard J, Wiley HE, Sen HN, Kodati S. Secondary Vitreoretinal Lymphoma With Spontaneous Regression. Am J Ophthalmol Case Rep. 2022;25:101357. doi:10.1016/j.ajoc.2022.101357
  131. Gan L, Ye J. Spontaneous Regression of Secondary Vitreoretinal Lymphoma After Diagnostic Vitrectomy: Case Report. BMC Ophthalmol. 2023;23(1):222. doi:10.1186/s12886-023-02967-5
  132. Hayashino K, Meguri Y, Yukawa R, et al. Spontaneous Regression of Dasatinib-Related Primary Effusion Lymphoma-Like Lymphoma. Int J Hematol. 2023;117(1):137–142. doi:10.1007/s12185-022-03449-y
  133. Li F, Wang L. Spontaneous Regression of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type After Biopsy. Indian J Dermatol Venereol Leprol. 2023;89(1):110–113. doi:10.25259/IJDVL_1055_19
  134. Aizawa K, Yamazaki F, Shima H, et al. A 15-Year-Old Boy with Primary Maxillary Bone Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma Relapsed with Rib Metastasis after Spontaneous Remission of a Maxillary Bone Lesion: A Case Report and Literature Review. Case Rep Oncol. 2023;16(1):308–314. doi:10.1159/000530459
  135. Abla D, Al-Battashi A, Albiroty K, Abu Qasida K, Al-Rahbi N, Al-Awaidy S. Spontaneous Remission of Angioimmunoblastic T-Cell Lymphoma in a Child With Ataxia-Telangiectasia: A Case Report. J Med Case Rep. 2023;17(1):347. doi:10.1186/s13256-023-04050-5
  136. Khaw ELY, Gan WF, Zaidan NZ. Spontaneous Regression of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in an HIV-Positive Patient: A Case Report and Literature Review. Cureus. 2024;16(3):e55790. doi:10.7759/cureus.55790
  137. Winkler M, Albrecht JD, Sauer C, et al. Spontaneous Regression of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: A Case Series and Review of the Literature. J Dermatol. 2024;51(9):1233–1239. doi:10.1111/1346-8138.17339
  138. Tomai RA, Iluta S, Tigu AB, et al. “Lazarus Response” When Feto-Maternal Microchimerism Kicks in: Spontaneous Remission in Refractory Primary Mediastinal B Cell Lymphoma Following Twin Pregnancy. Diagnostics (Basel). 2024;14(18):2084. doi:10.3390/diagnostics14182084
  139. Goto T, Hatano K, Kanemura N, Makita H, Goto H. Spontaneous Regression of Plasmablastic Lymphoma Associated With Methotrexate After Withdrawal. J Hematol. 2024;13(6):290–294. doi:10.14740/jh1361
  140. Teoh XY, Mashor Mansor M, Mohd Affandi A, Awang A, Faizah Baharom Z. Spontaneous Regression of Cutaneous T Cell Lymphoma in an HIV-Positive Patient. Leuk Lymphoma. 2025;66(4):794–796. doi:10.1080/10428194.2024.2433616
  141. Li S, Yu FH, Yanfen S. A Case of Spontaneous Remission of Non-Hodgkin's Lymphoma in the Lung. Clin Case Rep. 2025;
  142. Moreno, A., Curcó, N., Serrano, T., Garcia, J., Llistosella, E., & Bordas, X. (1991). Disseminated, miliarial type lymphocytoma cutis. A report of two cases. Acta dermato-venereologica, 71(4), 334–336. https://doi.org/10.2340/0001555571334336
  143. Weintraub LR. Lymphosarcoma: Remission Associated With Viral Hepatitis. JAMA. 1969;210(8):1590–1591. doi:10.1001/jama.1969.03160340198034
  144. Büchi, G., Termine, G., Zappalà, C., Girotto, M., Grosso, E., & Autino, R. (1983). spontaneous complete remission of CLL. report of a case studied with monoclonal antibodies. Acta haematologica, 70(3), 198–201. https://doi.org/10.1159/000206723
  145. Kwittken, J., & Goldberg, A. F. (1966). Follicular lymphoma of the skin. Archives of dermatology, 93(2), 177–183.
  146. Krikorian, J. G., Porightlock, C. S., Cooney, P., & Rosenberg, S. A. (1980). spontaneous regression of non-Hodgkin's lymphoma: a report of nine cases. Cancer, 46(9), 2093–2099. https://doi.org/10.1002/1097-0142(19801101)46:9<2093::aid-cncr2820460931>3.0.co;2-4
  147. Stevanovic & Majcan, 1961. Cutaneous Lymphoblastoma: report of two Cases with Unusual Courses. D.V. Stevanović, D.D. Majcan; Cutaneous Lymphoblastoma: report of two Cases with Unusual Courses. Dermatologica 1 April 1964; 129 (4): 329–338. https://doi.org/10.1159/000254646
  148. Gürçay A. spontaneous, temporary regression in a lymphosarcoma: can procaine produce this effect?. Turk J Pediatr 1969; 11: 9-17.
  149. monthstanaro, A., & Patton, R. (1976). Primary splenic malignant lymphoma, histiocytic type, with sclerosis: report of a case with long-term survival. Cancer, 38(4), 1625–1628. https://doi.org/10.1002/1097-0142(197610)38:4<1625::aid-cncr2820380430>3.0.co;2-x
  150. Williams M. V. (1980). spontaneous regression of cutaneous Hodgkin's disease. British medical journal, 280(6218), 903. https://doi.org/10.1136/bmj.280.6218.903
  151. Green, J. A., Arnold, A. M., Macbeth, F. R., Mead, G. M., Williams, C. J., Wright, D. H., & Whitehouse, J. M. (1984). Late recurrence in Hodgkin's disease: a report of two cases. Medical and pediatric oncology, 12(2), 148–149. https://doi.org/10.1002/mpo.2950120218
  152. Hernández Rubio, L., Giner Bernabeu, J. C., Perez Sempere, Á., & Toro, P. (2013). Primary cerebral lymphoma with spontaneous remission. Neurologia (Barcelona, Spain), 28(2), 123–126. https://doi.org/10.1016/j.nrl.2011.08.002
  153. Alcántara-González, J., González-García, C., Fernández-Guarino, M., & Jaén-Olasolo, P. (2014). spontaneous regression of primary diffuse large B-cell lymphoma, leg type. Actas dermo-sifiliograficas, 105(1), 78–83. https://doi.org/10.1016/j.ad.2012.07.009
  154. González Fernández, D., Valdés Pineda, F., Gómez Díez, S., & Vivanco Allende, B. (2015). Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoma With spontaneous Regression After Biopsy. Actas dermo-sifiliograficas, 106(9), 767–768. https://doi.org/10.1016/j.ad.2015.02.015
  155. Marrero-Alemán, G., monthstenegro-Dámaso, T., & Peñate, Y. (2017). Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With spontaneous Regression After Biopsy. The American Journal of dermatopathology, 39(10), 785–787. https://doi.org/10.1097/DAD.0000000000000874
  156. monthszen, Y., Nakahara, M., & Nishisaka, T. (2013). spontaneous regression of primary malignant lymphoma of the prostate. Case reports in urology, 2013, 363072. https://doi.org/10.1155/2013/363072
  157. Adiguzel, C., Bozkuright, S. U., Kaygusuz, I., Uzay, A., Tecimer, T., & Bayik, M. (2009). Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature. Apmis : acta pathologica, microbiologica, et immunologica Scandinavica, 117(3), 222–229. https://doi.org/10.1111/j.1600-0463.2008.00005.x
  158. Blokx, W. A., Andriessen, M. P., van Hamersvelt, H. W., & van Krieken, J. H. (2002). Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease. The American Journal of dermatopathology, 24(5), 414–422. https://doi.org/10.1097/00000372-200210000-00008
  159. Körner, S., Raab, P., Brandis, A., & Weissenborn, K. (2011). spontaneous regression of an intracerebral lymphoma (ghost tumor) in a liver-engrafted patient. The neurologist, 17(4), 218–221. https://doi.org/10.1097/NRL.0b013e318220c666
  160. Lelièvre, J. D., Sacre, K., Adle-Biassette, H., Molinier-Frenkel, V., Gaulard, P., & Papo, T. (2005). Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression. Journal of the American Academy of Dermatology, 52(2 Suppl 1), 24–27. https://doi.org/10.1016/j.jaad.2004.06.043
  161. Parekh, S. and Koduri, P.R. (2003), spontaneous regression of HIV-associated Hodgkin's disease. Am. J. Hematol., 72: 153-154. https://doi.org/10.1002/ajh.10289
  162. Tamás, L., Sári, E., Répássy, G. et al. spontaneous Remission in Localized Diffuse Large B-cell Lymphoma. Pathol. Oncol. Res. 17, 779–784 (2011). https://doi.org/10.1007/s12253-011-9379-6
  163. Nishimura, K., Oyama, N., Sekine, S., Shimizu, C., & Hasegawa, M. (2021). Spontaneous regression of long-standing bilateral nevoid hyperkeratosis of the nipple and areola in a young female: A case report. The Journal of dermatology, 48(4), e188–e189. https://doi.org/10.1111/1346-8138.15796
  164. Takatsu, H., Komatsu, T., Fukasawa, N., Fukuda, T., & Iguchi, Y. (2021). Spontaneously changing MRI findings of primary central nervous system vasculitis: A case report. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 83, 125–127. https://doi.org/10.1016/j.jocn.2020.11.012
  165. Han & Sokal, 1971. Spontaneous Remission of Leukemic Lymphoproliferative Disease. Cancer 27(3): March 1971; 586-595
  166. Getzen, J. H. 1967. Circulating Anticoagulant Due to Factor VIII Deficiency With Spontaneous Remission; Case Report. Southern Medical Journal 60(4): Apr 1967; 378-381
  167. Houbouyan et al., 1984. Lupus Anticoagulant and Acquired Prothrombin Deficiency During Viral Disease in a Child; Spontaneous Recovery. Archives Francaises de Pediatrie 41(6): Jun-Jul 1984; 417-420
  168. Ziliotto & Miotto, 1980. Angio-immunoblastic Lymphadenopathy with Spontaneous Remission in an Over 80-Year-Old Female Patient. Giornale di Gerontologia 28(8): 1980; (Recd 1981) 541-552
  169. Fiorillo et al., 1981. Angio-immunoblastic Lymphadenopathy with Dysproteinemia; Report of the First Case in Childhood Evolving Toward Spontaneous Remission. Cancer 48(7): Oct 1 1981; 1611-1614
  170. Matthews et al., 1988. A Case of Angio-immunoblastic Lymphadenopathy Associated with a Long Spontaneous Remission, Retrobulbar Neuritis, A Clonal Rearrangement of theT-Cell Receptor Gamma Chain Gene and an Unusual Marrow Infiltration. European Journal of Haematology 41(3): Sep 1988; 295-301